Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
24.68
Price to sales ratio
4.83

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
394
WAT
Waters Corporation Common Stock
373.24 USD-0.83%-2.37%+4.72%+21.67%36.65 B USD
409
IQV
IQVIA Holdings, Inc. Common Stock
207.53 USD-0.15%-0.97%+13.20%+28.49%34.64 B USD
500
MTD
Mettler-Toledo International, Inc. Common Stock
1299.65 USD+0.32%-0.03%+13.05%+8.26%26.26 B USD
551
DGX
Quest Diagnostics Incorporated Common Stock
207.38 USD-0.02%-3.80%+2.59%+23.04%22.96 B USD

Frequently asked questions about Illumina, Inc. - Common Stock

What is the Illumina, Inc. - Common Stock stock price today?

The current price of Illumina, Inc. - Common Stock (ILMN) is 190.05. Over the past 24 hours, the stock has changed by -0.08%. Follow the ILMN chart for real-time price dynamics.

What is the stock ticker of Illumina, Inc. - Common Stock?

Illumina, Inc. - Common Stock trades under the ticker ILMN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Illumina, Inc. - Common Stock stock going up?

ILMN has changed by -2.04% over the last week, +17.31% over the last month, and +91.97% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Illumina, Inc. - Common Stock net income for the last quarter?

Illumina, Inc. - Common Stock reported net income of 334 M for the last quarter. The previous quarter showed 150 M, which means net income changed by +122.67%.

How many employees does Illumina, Inc. - Common Stock have?

As of the latest available data, Illumina, Inc. - Common Stock has 8 650 employees. Workforce size can provide additional context about the company's scale and operations.

What is Illumina, Inc. - Common Stock EBITDA?

Illumina, Inc. - Common Stock EBITDA is 268 M, and its EBITDA margin is 23.04%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Illumina, Inc. - Common Stock stock?

You can buy Illumina, Inc. - Common Stock (ILMN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Illumina, Inc. - Common Stock stock?

Investing in Illumina, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ILMN chart and related analysis on metatrader.com as part of your research.

Illumina, Inc. - Common Stock

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

News